Invention Grant
- Patent Title: Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof
-
Application No.: US16700088Application Date: 2019-12-02
-
Publication No.: US11214569B2Publication Date: 2022-01-04
- Inventor: Gerald Horn
- Applicant: Lenz Therapeutics, Inc.
- Applicant Address: US CA Rancho Santa Fe
- Assignee: Lenz Therapeutics, Inc.
- Current Assignee: Lenz Therapeutics, Inc.
- Current Assignee Address: US CA Rancho Santa Fe
- Agency: Wood, Phillips, Katz, Clark & Mortimer
- Main IPC: C07D453/02
- IPC: C07D453/02 ; C07F9/59 ; C07F9/6561 ; C07D453/00 ; A61P27/06 ; A61K47/40
Abstract:
The present invention is directed to compounds of the formula and salts or esters thereof. The present invention is further directed to ophthalmological compositions comprising a therapeutically effective amount of a compound of the present invention and one or more pharmaceutically acceptable excipients. The present invention is further directed to a methods of treating presbyopia or glaucoma or reducing hyperemia comprising administering to a patient in need thereof a therapeutically effective amount of a compound of the present invention.
Public/Granted literature
- US20200181136A1 Prodrugs of Quinuclidine Ring-containing Muscarinic Agonists and Compositions and Methods Thereof Public/Granted day:2020-06-11
Information query
